DK3085777T3 - Polypeptid - Google Patents

Polypeptid Download PDF

Info

Publication number
DK3085777T3
DK3085777T3 DK16172568.4T DK16172568T DK3085777T3 DK 3085777 T3 DK3085777 T3 DK 3085777T3 DK 16172568 T DK16172568 T DK 16172568T DK 3085777 T3 DK3085777 T3 DK 3085777T3
Authority
DK
Denmark
Prior art keywords
polypeptide
Prior art date
Application number
DK16172568.4T
Other languages
English (en)
Inventor
Martin Johannes Loessner
Fritz Eichenseher
Original Assignee
Micreos Human Health Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44626456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3085777(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Micreos Human Health Bv filed Critical Micreos Human Health Bv
Application granted granted Critical
Publication of DK3085777T3 publication Critical patent/DK3085777T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462Lysozyme (3.2.1.17)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56938Staphylococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
DK16172568.4T 2011-05-04 2011-05-04 Polypeptid DK3085777T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16172568.4A EP3085777B1 (en) 2011-05-04 2011-05-04 A polypeptide
PCT/NL2011/050307 WO2012150858A1 (en) 2011-05-04 2011-05-04 A polypeptide
EP11720345.5A EP2705144B2 (en) 2011-05-04 2011-05-04 A polypeptide

Publications (1)

Publication Number Publication Date
DK3085777T3 true DK3085777T3 (da) 2020-02-03

Family

ID=44626456

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11720345.5T DK2705144T4 (da) 2011-05-04 2011-05-04 Polypeptid
DK16172568.4T DK3085777T3 (da) 2011-05-04 2011-05-04 Polypeptid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK11720345.5T DK2705144T4 (da) 2011-05-04 2011-05-04 Polypeptid

Country Status (15)

Country Link
US (2) US9382298B2 (da)
EP (2) EP2705144B2 (da)
JP (1) JP6261086B2 (da)
KR (1) KR101911114B1 (da)
CN (2) CN108192902A (da)
AU (1) AU2011367262B2 (da)
BR (1) BR112013028251B1 (da)
CA (1) CA2834924C (da)
DK (2) DK2705144T4 (da)
ES (2) ES2768777T3 (da)
HK (1) HK1195791A1 (da)
IL (1) IL229247B (da)
PL (2) PL2705144T3 (da)
SG (1) SG194776A1 (da)
WO (1) WO2012150858A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9206411B2 (en) * 2012-06-13 2015-12-08 The United States Of America, As Represented By The Secretary Of Agriculture Staphylococcal Phage2638A endolysin amidase domain is lytic for Staphylococcus aureus
PL3019185T3 (pl) * 2013-07-11 2021-08-02 Micreos Human Health B.V. Leczenie skojarzone atopowego zapalenia skóry
CN106795506B (zh) * 2014-05-14 2020-11-27 达特茅斯学院理事会 去免疫化溶葡萄球菌酶和使用方法
AU2016231141B2 (en) * 2015-03-12 2022-03-03 Micreos Human Health B.V. Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
EP3144387B1 (en) * 2015-09-15 2018-03-14 Micreos Human Health B.V. A novel endolysin polypeptide
EP3692149B1 (en) 2017-10-06 2023-01-04 Micreos Human Health B.V. Treatment of a condition associated with infection with an oncogenic bacterium
RU2020128276A (ru) * 2018-02-26 2022-03-29 Контрафект Корпорейшн МОДИФИЦИРОВАННЫЕ ЛИЗИНЫ PlySs2 И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ
JP7454211B2 (ja) 2020-01-20 2024-03-22 日本全薬工業株式会社 バクテリオファージ由来エンドライシン
WO2021185948A1 (en) 2020-03-19 2021-09-23 Micreos Human Health B.V. A stabilized protein of interest
WO2021213898A1 (en) * 2020-04-20 2021-10-28 Micreos Human Health B.V. A chimeric endolysin polypeptide.
WO2023049243A1 (en) * 2021-09-22 2023-03-30 Biomedit, Llc Lysostaphin variants and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2696864A1 (en) * 2007-08-22 2009-02-26 Hyglos Invest Gmbh New proteins for use in human and animal staphylococcus infections
ES2627321T3 (es) * 2008-07-03 2017-07-27 The Rockefeller University Una lisina de bacteriófago quimérica con actividad contra bacterias estafilocócicas
US8481289B2 (en) 2008-07-24 2013-07-09 The United States Of America, As Represented By The Secretary Of Agriculture Triple acting antimicrobials that are refractory to resistance development
EP2157100A1 (en) 2008-08-19 2010-02-24 Profos AG Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins
EP2563916B1 (en) * 2010-04-27 2015-07-08 Lysando AG Method of reducing biofilms
EP2993181A1 (en) * 2011-04-27 2016-03-09 Lysando AG New antimicrobial agents

Also Published As

Publication number Publication date
KR101911114B1 (ko) 2018-10-23
KR20140066976A (ko) 2014-06-03
DK2705144T4 (da) 2019-10-21
CN108192902A (zh) 2018-06-22
CN103703127A (zh) 2014-04-02
US10174300B2 (en) 2019-01-08
IL229247A0 (en) 2014-01-30
PL3085777T3 (pl) 2020-05-18
JP6261086B2 (ja) 2018-01-17
IL229247B (en) 2019-03-31
AU2011367262B2 (en) 2016-11-03
DK2705144T3 (da) 2016-09-05
ES2589784T5 (es) 2020-04-21
BR112013028251A2 (pt) 2017-01-17
EP2705144B1 (en) 2016-06-08
PL2705144T3 (pl) 2016-12-30
SG194776A1 (en) 2013-12-30
AU2011367262A1 (en) 2013-11-21
US9382298B2 (en) 2016-07-05
US20140127168A1 (en) 2014-05-08
EP2705144A1 (en) 2014-03-12
EP3085777A1 (en) 2016-10-26
EP2705144B2 (en) 2019-08-28
JP2014519815A (ja) 2014-08-21
US20160369255A1 (en) 2016-12-22
CA2834924C (en) 2022-08-16
ES2589784T3 (es) 2016-11-16
ES2768777T3 (es) 2020-06-23
EP3085777B1 (en) 2019-11-06
BR112013028251B1 (pt) 2021-04-06
WO2012150858A1 (en) 2012-11-08
HK1195791A1 (zh) 2014-11-21
CA2834924A1 (en) 2012-11-08

Similar Documents

Publication Publication Date Title
DK2728002T3 (da) Heterodimeriseret polypeptid
DK2940135T3 (da) Heterodimeriseret polypeptid
CO7020866A2 (es) Péptidos terapéuticos
CO6900146A2 (es) Imidazopiridazinas sustituidas con amino
BR112014004902A2 (pt) peptídeos
BR112013017629A2 (pt) laminina-521 recombinante
CO6862104A2 (es) Inmunotoxina recombinante dirigida a la mesotelina
DK2797616T3 (da) Celle-penetrerende peptider
BR112013020613A2 (pt) autoinjetor
FI20116181A (fi) Uusia terapeuttisia vektoreita
SG11201400432VA (en) Polypeptide vaccine
DK3085777T3 (da) Polypeptid
DK3384944T3 (da) Autoinjektor
CO6960543A2 (es) 2-tiopirimidinonas
DE102011100082A8 (de) Traygreifvorrichtung
FR2988733B1 (fr) Microorganisme recombinant
BR112013029769A2 (pt) levedura recombinante
BR112013024323A2 (pt) peptídeos neuroprotetores
CL2014002180A1 (es) Peptidos antomicrobianos
DE112011104936A5 (de) Stanzstauchniet
DK2861241T3 (da) Forbedrede cd31-peptider
FI20116212A (fi) Polypeptidi
DE112012000958A5 (de) Handsäge
DK2476953T3 (da) Fluidbedkedel
DE112012002458A5 (de) Hydrotransformator